Internal Medicine Alert - December 30, 2008

Target Audience:

This activity is intended for the internist and family practitioner.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Barbara A. Phillips, MD, MSPH
Professor of Medicine
University of Kentucky
Director Sleep Disorders Center
Samaritan Hospital

Rahul Gupta, MD, MPH, FACP
Assistant Professor, Department of Internal Medicine
Meharry Medical College Nashville, TN
Assistant Clinical Professor
Division of General Internal Medicine and Public Health
Vanderbilt University Medical School
Nashville, TN

Mary Elina Ferris, MD
Clinical Associate Professor
University of Southern California

Eileen C. West, MD
Director of Internal Medicine Women's Health
Clinical Associate Professor of Internal Medicine
University of Oklahoma College of Medicine
Oklahoma City

Louis Kuritzky, MD

Clinical Assistant Professor
University of Florida

William T. Elliott, MD, FACP

Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY


  • Which Smokers Get Lung Cancer?
  • Role of Long-term Secondary Prevention after MI
  • The Significance of Fatigue in the Elderly
  • Beating the Blues
  • Pharmacology Update: Silodosin Capsules (Rapaflo™)
  • Clinical Briefs By Louis Kuritzky, MD


  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert’s editor, Stephen Brunton, MD, is a consultant for Abbott, Amylin, Boehringer Ingelheim, Eli Lilly, Endo, Novartis, and Novo Nordisk. Associate editors Barbara A. Phillips, MD, MSPH, Rahul Gupta, MD, MPH, FACP, Mary Elina Ferris, MD, Eileen C. West, MD, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, and peer reviewer Gerald Roberts, MD, reports no financial relationship to this field of study. Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2008 AHC Media. All rights reserved.